T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome

Схожие документы

• Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
  по: Ishibashi, Kohei, et al.
  Опубликовано: (2017)
• Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
  по: Kohei Ishibashi, MD, PhD, et al.
  Опубликовано: (2017-04-01)
• Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator
  по: Karnik, Ankur A., et al.
  Опубликовано: (2017)
• Subcutaneous and transvenous implantable cardioverter defibrillator in high-risk long-QT syndrome type 3 associated with Val411Met mutation in SCN5A
  по: Yokoyama, Yasuhiro, et al.
  Опубликовано: (2020)
• Mobile subcutaneous implantable cardioverter-defibrillator leads to oversensing and inappropriate shocks
  по: Kiamanesh, Omid, et al.
  Опубликовано: (2019)